Open AccessDexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion
Author(s) -
Kyou Ho Lee,
Eui Chun Kang,
Hyoung Jun Koh
Publication year - 2017
Publication title -
korean journal of ophthalmology/korean journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.357
H-Index - 30
eISSN - 2092-9382
pISSN - 1011-8942
DOI - 10.3341/kjo.2017.31.2.108
Subject(s) - medicine , macular edema , ophthalmology , visual acuity , dexamethasone , bevacizumab , implant , branch retinal vein occlusion , central retinal vein occlusion , retinal vein , surgery , chemotherapy
To evaluate the prognostic factors and outcomes of dexamethasone intravitreal implant (DEX implant) for intravitreal bevacizumab refractory macular edema secondary to branch retinal vein occlusion (BRVO).